切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2020, Vol. 09 ›› Issue (02) : 172 -175. doi: 10.3877/cma.j.issn.2095-3232.2020.02.017

所属专题: 文献

临床研究

合并门静脉血栓患者肝移植术中血栓处理技巧
于里涵1, 汤睿1, 李昂1, 张新静1, 杨世伟1, 韩东冬1, 董家鸿1, 卢倩1,()   
  1. 1. 102218 北京,清华大学附属北京清华长庚医院肝胆胰中心
  • 收稿日期:2019-12-26 出版日期:2020-04-10
  • 通信作者: 卢倩
  • 基金资助:
    北京市医院管理局"扬帆"计划(ZYLX201712); 北京市医院管理局"使命"计划(SML20152201)

Intraoperative management of thrombosis in liver transplant patients complicated with portal vein thrombosis

Lihan Yu1, Rui Tang1, Ang Li1, Xinjing Zhang1, Shiwei Yang1, Dongdong Han1, Jiahong Dong1, Qian Lu1,()   

  1. 1. Hepatobiliary and Pancreatic Center, Beijing Tsinghua Changgung Hospital Affiliated to Tsinghua University, Beijing 102218, China
  • Received:2019-12-26 Published:2020-04-10
  • Corresponding author: Qian Lu
  • About author:
    Corresponding author: Lu Qian, Email:
引用本文:

于里涵, 汤睿, 李昂, 张新静, 杨世伟, 韩东冬, 董家鸿, 卢倩. 合并门静脉血栓患者肝移植术中血栓处理技巧[J]. 中华肝脏外科手术学电子杂志, 2020, 09(02): 172-175.

Lihan Yu, Rui Tang, Ang Li, Xinjing Zhang, Shiwei Yang, Dongdong Han, Jiahong Dong, Qian Lu. Intraoperative management of thrombosis in liver transplant patients complicated with portal vein thrombosis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2020, 09(02): 172-175.

目的

探讨术前合并门静脉血栓(PVT)患者肝移植术中血栓处理方法及疗效。

方法

回顾性分析2018年2月至2018年10月在清华大学附属北京清华长庚医院接受肝移植的10例合并PVT患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男7例,女3例;年龄37~66岁,中位年龄54岁。PVT分级标准采用Yerdel分级,Ⅰ级4例,Ⅱ级4例,Ⅲ级2例,无Ⅳ级患者。总结肝移植术中血栓处理方式和疗效。

结果

Ⅰ级血栓直接将血栓取出或高位离断门静脉主干,Ⅱ、Ⅲ级血栓根据血栓进展情况采用血栓剥除或取出全部血栓后行血管吻合,对于存在粗大分流血管者予以结扎离断。术后采用肝素静脉泵入和肝素皮下注射抗凝。术后超声定期监测门静脉血流,复查6个月,所有患者术后超声均证实门静脉血流正常通畅,无门静脉新发血栓形成、狭窄、血流不足等门静脉相关并发症发生。

结论

对于合并PVT肝移植患者,为了获得足够的移植物门静脉血流,术前须评估PVT的范围及阻塞程度,设计精确的手术方案。根据不同情况PVT予以相应处理,可保证术后门静脉供血通畅,减少并发症发生。

Objective

To explore the managements for intraoperative thrombosis in liver transplant patients complicated with portal vein thrombosis (PVT) and its efficacy.

Methods

Clinical data of 10 patients complicated with PVT who underwent liver transplantation between February 2018 and October 2018 in Beijing Tsinghua Changgung Hospital Affiliated to Tsinghua University were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 7 patients were male and 3 female, aged 37-66 years old with a median age of 54 years old. PVT was classified based on Yerdel classification. Among them, 4 cases were classified as grade Ⅰ, 4 grade Ⅱ and 2 grade Ⅲ. The managements for intraoperative thrombosis were summarized and clinical efficacy was evaluated.

Results

For patients with grade Ⅰ thrombosis, the thrombi were removed directly or treated by dissecting the portal vein trunk at the high end. According to the progression of thrombi, grade Ⅱ and Ⅲ thrombi were removed directly, or vascular anastomosis was performed after the removal. The large shunt vessels were ligated and dissected. After the operation, intravenous or subcutaneous injection of heparin was given for anticoagulation. The portal vein blood flow was monitored by ultrasound periodically after operation. During 6-month follow-up, postoperative ultrasound demonstrated normal portal vein blood flow in all patients. No portal vein-related complications, such as new PVT, stenosis and insufficient blood flow, occurred.

Conclusions

For patients complicated with PVT, assessment of range and severity of PVT should be performed before operation to obtain sufficient portal vein blood flow of the graft, and to design a precise surgical plan. PVT can be treated according to individual conditions to guarantee the well blood flow of portal vein and to reduce the postoperative complications.

图1 Yerdel分级Ⅱ级门静脉血栓肝移植患者CT图像及术中处理过程
[1]
Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome[J]. Transplantation, 2000, 69(9):1873-1881.
[2]
Langnas AN, Marujo WC, Stratta RJ, et al. A selective approach to preexisting portal vein thrombosis in patients undergoing liver transplantation[J]. Am J Surg, 1992, 163(1):132-136.
[3]
Doenecke A, Tsui TY, Zuelke C, et al. Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity[J]. Clin Transplant, 2010, 24(1):48-55.
[4]
Gao PJ, Gao J, Li Z, et al. Liver transplantation in adults with portal vein thrombosis: data from the China Liver Transplant Registry[J]. Clin Res Hepatol Gastroenterol, 2016, 40(3):327-332.
[5]
Schaubel DE, Guidinger MK, Biggins SW, et al. Survival benefit-based deceased-donor liver allocation[J]. Am J Transplant, 2009, 9(4 Pt 2):970-981.
[6]
Ravaioli M, Zanello M, Grazi GL, et al. Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna[J]. Ann Surg, 2011, 253(2):378-384.
[7]
Zocco MA, Di Stasio E, De Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development[J]. J Hepatol, 2009, 51(4):682-689.
[8]
Han DH, Joo DJ, Kim MS, et al. Living donor liver transplantation for advanced hepatocellular carcinoma with portal vein tumor thrombosis after concurrent chemoradiation therapy[J]. Yonsei Med J, 2016, 57(5):1276-1281.
[9]
Karvellas CJ, Cardoso FS, Senzolo M, et al. Clinical impact of portal vein thrombosis prior to liver transplantation: a retrospective cohort study[J]. Ann Hepatol, 2017, 16(2):236-436.
[10]
滕飞,傅志仁.肝移植中基于门静脉重建方案的门静脉血栓分类及处理策略[J].器官移植,2018, 9(4):245-249.
[11]
王文静,胡安斌,陈庆,等.门静脉血栓对终末期肝硬化病人行肝移植手术的影响[J].腹部外科,2016, 29(5):363-367.
[12]
Hibi T, Nishida S, Levi DM, et al. When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases[J]. Ann Surg, 2014, 259(4):760-766.
[13]
D'Amico G, Tarantino G, Spaggiari M, et al. Multiple ways to manage portal thrombosis during liver transplantation: surgical techniques and outcomes[J]. Transplant Proc, 2013, 45(7):2692-2699.
[14]
Rodríguez-Castro KI, Porte RJ, Nadal E, et al. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review[J]. Transplantation, 2012, 94(11):1145-1153.
[15]
Molmenti EP, Roodhouse TW, Molmenti H, et al. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation[J]. Ann Surg, 2002, 235(2):292-296.
[16]
Mori A, Iida T, Iwasaki J, et al. Portal vein reconstruction in adult living donor liver transplantation for patients with portal vein thrombosis in single center experience[J]. J Hepatobiliary Pancreat Sci, 2015, 22(6):467-474.
[17]
Chikamori F, Nishida S, Selvaggi G, et al. Effect of liver transplantation on spleen size, collateral veins, and platelet counts[J]. World J Surg, 2010, 34(2):320-326.
[18]
Manzia TM, Fazzolari L, Manuelli M, et al. Liver transplantation ina patient with complete portal vein thrombosis, is there a surgical way out? a case report[J]. Ann Med Surg, 2016(11):5-8.
[19]
Simón-Talero M, Roccarina D, Martínez J, et al. Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis[J]. Gastroenterology, 2018, 154(6):1694-1705, e4.
[20]
Golse N, Mohkam K, Rode A, et al. Surgical management of large spontaneous portosystemic splenorenal shunts during liver transplantation: splenectomy or left renal vein ligation[J]. Transplant Proc, 2015, 47(6):1866-1876.
[21]
Dumortier J, Czyglik O, Poncet G, et al. Eversion thrombectomy for portal vein thrombosis during liver transplantation[J]. Am J Transplant, 2002, 2(10):934-938.
[22]
Miura K, Sugawara Y, Uchida K, et al. Adult living donor liver transplantation for patients with portal vein thrombosis: a single-center experience[J]. Transplant Direct, 2018, 4(5):e341.
[1] 李坤河, 寇萌佳, 邝立挺. 肝移植术后二次气管插管的危险因素及预测模型的建立[J]. 中华普通外科学文献(电子版), 2023, 17(05): 366-371.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 莫闲, 杨闯. 肝硬化患者并发门静脉血栓危险因素的Meta分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 678-683.
[4] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[5] 陆闻青, 陈昕怡, 任雪飞. 遗传代谢病儿童肝移植受者术后生活质量调查研究[J]. 中华移植杂志(电子版), 2023, 17(05): 287-292.
[6] 范铁艳, 李君, 陈虹. 肝移植术后新发戊型病毒性肝炎的诊治经验[J]. 中华移植杂志(电子版), 2023, 17(05): 293-296.
[7] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[8] 汤鹏昊, 张武. 肠道微生态与肝移植围手术期并发症相关研究进展[J]. 中华移植杂志(电子版), 2023, 17(05): 303-307.
[9] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[10] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[11] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[12] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[13] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[14] 王孟龙. 肿瘤生物学特征在肝癌肝移植治疗中的意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 490-494.
[15] 王迪, 吕少诚, 黄金灿, 潘飞, 姜涛, 郎韧. 肺腺癌胰腺转移伴门静脉侵犯一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 457-460.
阅读次数
全文


摘要